Recent Articles from Business Wire

AM Best has placed under review with positive implications the Financial Strength Rating of A+ (Superior), the Long-Term Issuer Credit Rating of “aa-” (Superior) and the Mexico National Scale Rating of “aaa.MX” (Exceptional) of Sompo Seguros Mexico, S.A. de C.V. (Sompo Mexico) (Mexico City, Mexico).

The "Global Market Intelligence Database Market Model" subscription has been added to ResearchAndMarkets.com's offering.

The "STAT Inhibitors - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering.

It was announced today that GaN (Gallium Nitride)-based e-Beam inspection and metrology for advanced semiconductor manufacturing, jointly developed by Nagoya University startup Photo electron Soul Inc. (PeS; CEO: Takayuki Suzuki) and the Nagoya University Amano-Honda Laboratory, will be evaluated by Kioxia Iwate Corporation (President and CEO: Koichiro Shibayama) in late September. During the critical field test, Kioxia Iwate will evaluate and verify the benefits of adopting this advanced technology to improve overall manufacturing yield by enhancing defect detection and root-cause analysis within live inspection and metrology processes.

The LYCRA Company, a global leader in developing fiber and technology solutions for the apparel and personal care industries, returns to Intertextile Shanghai (Sept. 2–4) with an exclusive global sneak preview of its latest denim innovation.

AM Best has placed under review with positive implications the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of Sompo Japan Insurance Inc. (SJ) (Japan) and its subsidiaries. Concurrently, AM Best has placed under review with positive implications the Long-Term ICR of “a-” (Excellent) of Sompo International Holdings Ltd. (SIH) (Pembroke, Bermuda). In addition, AM Best has placed under review with positive implications the Long-Term Issue Credit Rating of “a-” (Excellent) on $335 million 7% senior unsecured notes due by 2034, which is guaranteed by SIH.

The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering.

Regulatory News:

Mindbreeze, a leading global provider of AI-based knowledge management solutions, announced the release of its 2H 2025 GenAI Confidence Index Report today. Top results show that the vast majority of the C-suite (82 percent) have high confidence in GenAI at an industry level and a significant increase (16 percent) in confidence that enterprises can find a vendor to implement GenAI to provide solid operational benefits properly.

Montage Technology today announced the launch of its CXL® 3.1 Memory eXpander Controller (MXC, Part No. M88MX6852), now in sampling phase with key customers. Compliant with the CXL 3.1 Type 3 specification, the controller supports both CXL.mem and CXL.io protocols, delivering high-bandwidth, low-latency memory expansion and pooling solutions for next-generation data center servers.

BoldAge PACE is proud to join programs nationwide in celebrating National PACE Month, highlighting how the Program of All-Inclusive Care for the Elderly (PACE) keeps older adults healthy, independent and thriving in their homes and communities.

The "Spasticity - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.

The "Corneal Ulcer Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

xSuite Group has released version 5.2.14 of its SAP-integrated Business Solutions. The release delivers new features for the components xSuite Invoice, xSuite Procurement, xSuite Order Confirmation, and xSuite Orders. Key focus is on processing purchase order-related invoices (SAP MM) with the goal of achieving a 100% touchless rate across the entire invoice workflow. The workflow suite also introduces expanded AI functionalities.

The "Dyslipidemia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

500 Global, one of the world’s most active venture capital firms1, and dcamp, South Korea’s premier foundation dedicated to fostering entrepreneurship, today announced a strategic partnership aimed to accelerate Korean startups’ growth as they expand to the US market.

The "Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The "Tardive Dyskinesia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The "Autism Spectrum Disorder Market - A Global and Regional Analysis: Focus on Type of Disease, Drug Class, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The "Still's Disease Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The "Code Storage Flash Forecast SPI NAND and Serial NOR Flash SWOT Analysis 2025" report has been added to ResearchAndMarkets.com's offering.

The "New Payment Services Regulations: PSD3, MiCAR and PCI DSS (ONLINE EVENT: October 13, 2025)" workshop has been added to ResearchAndMarkets.com's offering.

The "Vision 2030: India's Growth Frontiers" report has been added to ResearchAndMarkets.com's offering.

The "Global Supercapacitors Market 2026-2036" report has been added to ResearchAndMarkets.com's offering.

The "Liquid Biopsy Market Industry Trends and Global Forecasts to 2035, by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-user, Type of Technique, and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

The "Digital Twins in Healthcare Market Industry Trends and Global Forecasts to 2035: Distribution by Therapeutic Area, Type of Digital Twin, Areas of Application, End Users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

The Wi-Fi HaLow (802.11ah) market is expected to grow steadily over the next five years, at a compound annual growth rate (CAGR) of 79%, according to Omdia’s new report released month: “Wi-Fi HaLow (802.11ah) Market Assessment”.

Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Sandro Galfetti has joined the firm as a Managing Director in the firm’s Capital Solutions Group. He will be based in Zurich.

k-ID, the global compliance platform transforming age-appropriate digital experiences for young people worldwide, today announced the appointment of Mike Mongeau as Head of Product. Mongeau joins k-ID from Microsoft, where he spearheaded Xbox’s family gaming experience, ensuring millions of kids could game safely while giving parents the tools to feel confident about their play.

Daytrip, a global travel platform providing private door-to-door car transfers and day trips with English-speaking drivers and optional sightseeing stops in over 130 countries worldwide, is celebrating its 10th anniversary this September. To mark the occasion, the travel company gives travelers a chance to win 10 day trips, thus helping them explore hidden gems in over 300 locations as a part of their trip with a private English-speaking driver that brings them back to their original destination. To participate in the giveaway, people are encouraged to visit @mydaytrip and interact with the giveaway post.*

Apple® today previewed its newest store in India, Apple Hebbal, located in the technology capital of Bengaluru. The store will be Apple’s first in South India and third in the country, joining Apple BKC in Mumbai and Apple Saket in Delhi and the Apple Store online. Apple Hebbal will be a welcoming space for customers to shop Apple’s full lineup of products, experience the best service and support, and participate in free Today at Apple sessions to discover and learn how to get the most out of their devices.

Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over half a billion devices, has launched its AI Virtual Smart Sensor Platform™ on six smartphone models in August 2025. HONOR launched one smartphone: the HONOR Play 70 Plus. vivo announced two smartphones: the vivo TR4 and iQOO Z10R smartphones. Xiaomi shipped two smartphones: the Redmi Note 15 and Redmi Note 15 Pro. Lastly, Transsion announced one smartphone: the Infinix GT30. For 2025 year-to-date, Elliptic Labs has launched on a total of 45 smartphone models.

Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) reports today that sulphide copper production is temporarily impacted due to a motor failure in the ball mill at the Mantoverde mine in Chile.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Cardiology (ESC) Congress 2025 held in Madrid, Spain. These data reflect outcomes of treatment through up to 48 months, including the initial double-blind period of 33-36 months, and highlight the ongoing clinical benefit of vutrisiran, which causes rapid knockdown of the disease-causing transthyretin (TTR) protein, including a 37% risk reduction in the composite endpoint of all-cause mortality (ACM) or first cardiovascular (CV) event in the overall population (p<0.001) and a 42% risk reduction in the monotherapy group (p<0.001), reinforcing vutrisiran’s potential as a first-line treatment for patients with ATTR-CM. Vutrisiran also reduced the risk of ACM alone by 37% in the overall population (p<0.01) and 39% in the monotherapy group (p<0.01) during this same period.

Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre.

Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that on August 29, 2025, the U.S. Government filed a Statement of Interest in the pending New York federal court litigation regarding the validity of the 2020 PDVSA bonds.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from the comprehensive KARDIA Phase 2 program, including KARDIA-3 results presented today as a late-breaking abstract at the European Society of Cardiology (ESC) Congress in Madrid, Spain. Zilebesiran is an investigational subcutaneously administered RNAi therapeutic which, in the KARDIA Phase 2 program, has shown reductions in blood pressure by targeting liver-expressed angiotensinogen (AGT), the most upstream precursor in the Renin-Angiotensin-Aldosterone System (RAAS), which plays a key role in blood pressure regulation and impacts cardiovascular and renal health.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam (Nasdaq: ALNY) today announced the decision to initiate a Phase III cardiovascular outcomes trial (CVOT) to evaluate the ability of zilebesiran, an RNAi therapeutic, to reduce the risk of major adverse cardiovascular events in patients with uncontrolled hypertension. This decision was informed by the comprehensive KARDIA Phase II program, including KARDIA-1, KARDIA-2 and the most recent KARDIA-3 study evaluating the efficacy and safety of zilebesiran in patients with uncontrolled hypertension and high cardiovascular (CV) risk, on two to four standard of care antihypertensives. In particular, KARDIA-3 aimed to define the patient population to be investigated in the Phase III CV outcomes trial.

Positive full results from the ​BaxHTN Phase III trial showed ​baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean seated systolic blood pressure (SBP) at two doses (2mg and 1mg) compared with placebo at 12 weeks. Results were seen in patients with hard-to-control (uncontrolled and resistant) hypertension who received baxdrostat or placebo on top of standard of care.

FS, a trusted global provider of ICT products and solutions, announced the launch of its independently developed DCS-W Series All-Optical Circuit Switch (OCS). Designed to meet the surging demands of AI, HPC, and machine learning clusters, the DCS-W Series combines a fully non-blocking optical matrix switch architecture with an intuitive Web GUI management system, enabling networks to move beyond basic connectivity toward intelligent and programmable control.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results evaluating VERQUVO® (vericiguat) in adult patients with stable chronic heart failure and reduced ejection fraction (HFrEF). The Phase 3 VICTOR trial comparing the efficacy of VERQUVO to placebo in patients with HFrEF without a recent worsening heart failure event treated with guideline-directed medical therapy (GDMT) did not reach statistical significance for its primary endpoint of combined time to first event of cardiovascular death or hospitalization for heart failure. In a separate pre-specified pooled analysis of patient-level data from the complementary Phase 3 VICTOR and VICTORIA trials, VERQUVO reduced the risk of the composite primary endpoint of cardiovascular death or heart failure hospitalization across these patients with a broad range of disease severity. Results from both analyses were presented today at the European Society of Cardiology (ESC) Congress 2025 in a Hot Line session and simultaneously published in The Lancet.

Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that its Delaware subsidiary, Dalinar Energy Corporation (“Dalinar Energy”), was not selected by the Special Master as the recommended bidder for the purchase of the shares of PDV Holding, Inc. (“PDVH”), the indirect parent company of CITGO Petroleum Corp., in the sales process being conducted by the U.S. District Court for the District of Delaware (the “Court”). Amber Energy Inc. was named in the Updated Final Recommendation.

Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Exelixis, Inc. (Nasdaq: EXEL) today announced it has appointed Dana T. Aftab, Ph.D., as its Executive Vice President, Research and Development. In this new role, Dr. Aftab will oversee all aspects of the company’s drug discovery, translational research, product development and medical affairs activities.

Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announces Dustin Sedgwick has joined the company as Chief Marketing Officer.

On September 4, 2025, San Francisco Bay University (SFBU) will launch Innovate Bay, a new on-campus business incubator created to connect student founders, technologists, and first-time entrepreneurs with industry resources, providing the tools, mentorship, and environment to turn bold ideas into viable ventures.

MAC Copper Limited ARBN 671 963 198 (NYSE:MTAL; ASX:MAC)

Funko, Inc. (Nasdaq: FNKO) (the “Company” or “Funko”), a leading pop culture lifestyle brand, announced today that Funko’s Board of Directors, on the recommendation of Funko’s Compensation Committee, has granted an inducement restricted stock unit award to Funko’s new Chief Executive Officer, Josh Simon, under the Funko, Inc. 2024 Inducement Award Plan (the “Inducement Plan”) covering 1,000,000 shares of the Company’s Class A common stock, effective as of September 1, 2025. The award will vest over four years in four equal annual installments on each of the first four anniversaries of September 1, 2025, subject to Mr. Simon’s continued employment through the applicable vesting dates, and will be subject to acceleration in full upon a change in control (as defined in the Inducement Plan). The award was granted as an inducement material to Mr. Simon’s entering into employment with Funko, in accordance with and in reliance upon Nasdaq Listing Rule 5635(c)(4) and is subject to the Inducement Plan and an award agreement thereunder covering the grant.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. (“Semler” or “the Company”) (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the “ATM Program”) that allows Canopy Growth to issue and sell up to US$200 million of common shares of the Company (“Common Shares”) from treasury from time to time in concurrent public offerings in the United States (the “U.S. Offering”) and Canada; provided, however, that (i) sales of Common Shares in the ATM Program in Canada is limited to aggregate gross sales proceeds to the Company of up to US$50 million (or its Canadian dollar equivalent) (the “Canadian Offering”); and (ii) in no event will the combined gross sales proceeds of the ATM Program in the United States and Canada exceed US$200 million. Any Common Shares sold in the ATM Program will be sold in transactions made directly on the Nasdaq or the TSX or on any other available U.S. or Canadian trading market for the Common Shares. The volume and timing of sales under the ATM Program, if any, will be determined in the Company’s sole discretion and are subject to customary conditions precedent. The Common Shares will be distributed at market prices prevailing at the time of each sale or at certain other prices and, as a result, prices may vary as between purchasers and during the period of distribution under the ATM Program.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on August 29, 2025.

Common shareholders of Nuveen Preferred Securities & Income Opportunities Fund (NYSE: JPI) and preferred shareholders of Nuveen Preferred & Income Opportunities Fund (NYSE: JPC) have approved a proposal to merge the funds. The merger will combine JPI into JPC. Subject to the satisfaction of certain customary closing conditions, the merger is expected to become effective before the market opens on September 22, 2025.

University of Florida Health will continue providing expert medical care to Team USA athletes through the Milano-Cortina 2026 Olympic Winter Games in Italy and the Los Angeles 2028 Olympic and Paralympic Games under an extended agreement with the U.S. Olympic & Paralympic Committee.

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share:

The Principal Real Estate Income Fund (NYSE:PGZ) announces the sources of a distribution paid on August 29, 2025 of $0.1050 per share to shareholders of record at the close of business on August 15, 2025, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission and includes the notice below sent to shareholders regarding the source of the distribution.

On August 29, 2025, the Board of Governors of the Federal Reserve System announced that it was continuing to review Morgan Stanley’s request for a downward adjustment to the Firm’s preliminary Stress Capital Buffer (SCB) requirement. Morgan Stanley remains actively engaged with the Federal Reserve to reach a final SCB requirement before the October 1, 2025 effective date.

PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY) and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) declared today monthly distributions for September, October and November 2025. The distribution amounts and schedule for each fund appears below:

IF Bancorp, Inc. (NASDAQ: IROQ) (the “Company”) the holding company for Iroquois Federal Savings and Loan Association (the “Association”), announced net income of $4.3 million, or $1.37 per basic share and diluted share for the fiscal year ended June 30, 2025, compared to $1.8 million, or $0.57 per basic and diluted share for the fiscal year ended June 30, 2024. The Company also announced net income of $1.4 million, or $0.45 per basic share and diluted share for the three months ended June 30, 2025, compared to $431,000, or $0.13 per basic and diluted share for the three months ended June 30, 2024.

WNS (Holdings) Limited (NYSE: WNS) (“WNS”), a digital-led business transformation and services company, today announced that its shareholders overwhelmingly voted to approve the acquisition by Capgemini SE (EUR: CAP) (“Capgemini”) at a special court-ordered meeting of the shareholders (“Court Meeting”) and General Meeting of Shareholders (“General Meeting”), each held on August 29, 2025. Approximately 99.9% of the shares voted were cast in favor of the transaction, representing approximately 79.2% of WNS’ total outstanding shares as of the voting record date.

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

Piedmont Lithium Inc. (“Piedmont,” the “Company”) (Nasdaq: PLL; ASX: PLL), a leading North American supplier of lithium products critical to the U.S. electric vehicle supply chain, today announced the successful completion of the merger with Sayona Mining Limited (“Sayona”) (Nasdaq: ELVR; ASX: SYA; OTCQB: SYAXF) (the “Merger”) following approval by shareholders of both companies and the satisfaction of all closing conditions.

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Friday, September 5, 2025 at 7:55am ET.

Paubox, the leading provider of HIPAA compliant email security, today unveiled its most ambitious product release to date—Inbound Email Security, the AI-powered inbound email security solution that improves upon rule-based filters with generative artificial intelligence.

The Eaton Vance closed-end funds listed below released today the estimated sources of their August distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the August distribution. It is not determinative of the tax character of a Fund’s distributions for the 2025 calendar year. Shareholders should note that each Fund’s total regular distribution amount is subject to change as a result of market conditions or other factors.

Paladin EnviroTech, a rapidly growing leader in IT Asset Disposition (ITAD) and sustainable electronics recycling, is proud to announce the appointment of Keith Layton as Senior Vice President of Remarketing. Layton joins Paladin’s executive team at a pivotal time, as the company accelerates its national expansion and deepens its commitment to circular economy principles.

Navajo Transitional Energy Company (NTEC) is proud to announce the first of 125 home solar installations on the Navajo Nation, funded by NTEC and a grant from the U.S. Department of Energy (DOE) Office of Clean Energy Demonstrations (OCED). The installation took place on a remote hogan in the Oljato Chapter of the Navajo Nation. More than 13,000 homes on the Navajo Nation are currently not connected to the electric grid, which limits access to adequate water, refrigeration, cooling, and connectivity. Programs like NTEC’s Navajo Sun Power! provides Navajo homes with solar power that electrify Navajo homes and make them eligible for other critical upgrades and public services.

The "Mexico Construction Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.

The "China Construction Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)" report has been added to ResearchAndMarkets.com's offering.

Striveworks, a leading developer of cutting-edge artificial intelligence solutions, today announced its selection to deliver operational AI solutions to support the force protection of U.S. Army soldiers operating along the border separating the U.S. from Mexico as part of U.S. Northern Command’s Joint Task Force-Southern Border.

The "Singapore Construction Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)" report has been added to ResearchAndMarkets.com's offering.

PitchBook, the premier data provider for the private and public equity markets, today announced it was recognized as one of Washington’s Best Workplaces by Puget Sound Business Journal (PSBJ) in the Extra Large category, which includes companies with 250+ employees in Washington. Recipients are selected and ranked based on employee satisfaction surveys, which review benefit offerings, leadership, collaboration, growth opportunities, team dynamics and more. As a winner for the 11th year, PitchBook placed 7th on the 2025 list.

Tel Instrument Shareholders:

Clear Fracture LLC, a company heating up the AI data integration space for national security missions, today announced that it has listed its AI-powered data integration solutions in the AWS Marketplace for the U.S. Intelligence Community (ICMP). ICMP is a curated digital catalog from Amazon Web Services (AWS) that makes it easy to discover, purchase, and deploy software packages and applications from vendors that specialize in supporting government customers.

Today, Citizens Against Government Waste (CAGW) named Sen. Susan Collins (R-Maine) its August 2025 Porker of the Month for leading the way in Congress on wasting taxpayer dollars for self-serving pork-barrel earmarks.